Influence of Human Allogenic Bone Marrow and Cord Blood-Derived Mesenchymal Stem Cell Secreting Trophic Factors on ATP (adenosine-5′-triphosphate)/ADP (adenosine-5′-diphosphate) Ratio and Insulin Secretory Function of Isolated Human Islets From Cadaveric Donor

Transplantation Proceedings

Volumn 41, Issue 9, 2009, Pages 3813-3818

  Park, K S ^a,b   Kim, Y S ^a,b   Kim, J H ^b   Choi, B K ^a,b   Kim, S H ^b   Oh, S H ^b   Ahn, Y R ^b   Lee, M S ^b   Lee, M K ^b   Park, J B ^a   Kwon, C H ^a   Joh, J W ^a   Kim, K W ^b   Kim, S J ^a,b  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; INSULIN; INTERLEUKIN 6; SCATTER FACTOR; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A;

ALLOGENIC BONE MARROW TRANSPLANTATION; ANGIOGENESIS; ARTICLE; CADAVER; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN RELEASE; MESENCHYMAL STEM CELL; PANCREAS ISLET; PRIORITY JOURNAL; REVASCULARIZATION; SURVIVAL; UMBILICAL CORD BLOOD;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; BONE MARROW CELLS; CADAVER; CELL SEPARATION; CENTRIFUGATION, DENSITY GRADIENT; COCULTURE TECHNIQUES; CORD BLOOD STEM CELL TRANSPLANTATION; DIABETES MELLITUS, TYPE 1; ENZYME-LINKED IMMUNOSORBENT ASSAY; FETAL BLOOD; HUMANS; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MESENCHYMAL STEM CELLS; TISSUE DONORS;

EID: 71749091230     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2009.06.193     Document Type: Article

References (30)

1. Shapiro A.M., Lakey J.R., Ryan E.A., et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343 (2000) 230
2. Shapiro A.M., Ricordi C., and Hering B. Edmonton's islet success has indeed been replicated elsewhere. Lancet 362 (2003) 1242
3. Ryan E.A., Paty B.W., Senior P.A., et al. Five-year follow-up after clinical islet transplantation. Diabetes 54 (2005) 2060
4. Shapiro A.M., Ricordi C., Hering B.J., et al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med 355 (2006) 1318
5. Miki A., Narushima M., Okitsu T., et al. Maintenance of mouse, rat, and pig pancreatic islet functions by coculture with human islet-derived fibroblasts. Cell Transplant 15 (2006) 325
6. Froud T., Ricordi C., Baidal D.A., et al. Islet transplantation in type 1 diabetes mellitus using cultured islets and steroid-free immunosuppression: Miami experience. Am J Transplant 5 (2005) 2037
7. Alejandro R., Latif Z., Noel J., et al. Effect of anti-Ia antibodies, culture, and cyclosporin on prolongation of canine islet allograft survival. Diabetes 36 (1987) 269
8. Goto M., Yoshikawa Y., Matsuo K., et al. Optimization of a prominent oxygen-permeable device for pancreatic islets. Transplant Proc 40 (2008) 411
9. Ricordi C., Fraker C., Szust J., et al. Improved human islet isolation outcome from marginal donors following addition of oxygenated perfluorocarbon to the cold-storage solution. Transplantation 75 (2003) 1524
10. Ilieva A., Yuan S., Wang R.N., et al. Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. J Endocrinol 161 (1999) 357
11. Caplan A.I., and Dennis J.E. Mesenchymal stem cells as trophic mediators. J Cell Biochem 98 (2006) 1076
12. Li N., Feugier P., Serrurrier B., et al. Human mesenchymal stem cells improve ex vivo expansion of adult human CD34+ peripheral blood progenitor cells and decrease their allostimulatory capacity. Exp Hematol 35 (2007) 507
13. van Poll D., Parekkadan B., Cho C.H., et al. Mesenchymal stem cell-derived molecules directly modulate hepatocellular death and regeneration in vitro and in vivo. Hepatology 47 (2008) 1634
14. Lataillade J.J., Doucet C., Bey E., et al. New approach to radiation burn treatment by dosimetry-guided surgery combined with autologous mesenchymal stem cell therapy. Regen Med 2 (2007) 785
15. Zhang M., Mal N., Kiedrowski M., et al. SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J 21 (2007) 3197
16. Park H.J., Lee P.H., Bang O.Y., et al. Mesenchymal stem cells therapy exerts neuroprotection in a progressive animal model of Parkinson's disease. J Neurochem 107 (2008) 141
17. Jung H.S., Choi S.H., Kim S.J., et al. A better yield of islet cell mass from living pancreatic donors compared with cadaveric donors. Clin Transplant 21 (2007) 738
18. Bieback K., Kern S., Klüter H., et al. Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood. Stem Cells 22 (2004) 625
19. Goto M., Holgersson J., Kumagai-Braesch M., et al. The ADP/ATP ratio: a novel predictive assay for quality assessment of isolated pancreatic islets. Am J Transplant 6 (2006) 2483
20. Miwa I., and Taniguchi S. Acceleration by fructose of the ATP-sensitive K(+) channel-independent pathway of glucose-induced insulin secretion. Horm Metab Res 34 (2002) 450
21. Brandhorst D., Brandhorst H., Hering B.J., et al. Large variability of the intracellular ATP content of human islets isolated from different donors. J Mol Med 77 (1999) 93
22. Ilieva A., Yuan S., Wang R.N., et al. Pancreatic islet cell survival following islet isolation: the role of cellular interactions in the pancreas. J Endocrinol 161 (1999) 357
23. Giuliani M., Moritz W., Bodmer E., et al. Central necrosis in isolated hypoxic human pancreatic islets: evidence for postisolation ischemia. Cell Transplant 14 (2005) 67
24. Bonner-Weir S., and Orci L. New perspectives on the microvasculature of the islets of Langerhans in the rat. Diabetes 31 (1982) 883
25. Choi S.E., Choi K.M., Yoon I.H., et al. IL-6 protects pancreatic islet beta cells from pro-inflammatory cytokines-induced cell death and functional impairment in vitro and in vivo. Transpl Immunol 13 (2004) 43
26. Cheng Y., Liu Y.F., Zhang J.L., et al. Elevation of vascular endothelial growth factor production and its effect on revascularization and function of graft islets in diabetic rats. World J Gastroenterol 13 (2007) 2862
27. Fiaschi-Taesch N.M., Berman D.M., Sicari B.M., et al. Hepatocyte growth factor enhances engraftment and function of nonhuman primate islets. Diabetes 57 (2008) 2745
28. Hanley S., and Rosenberg L. Transforming growth factor beta is a critical regulator of adult human islet plasticity. Mol Endocrinol 21 (2007) 1467
29. Garcia-Ocana A., Takane K.K., Reddy V.T., et al. Adenovirus-mediated hepatocyte growth factor expression in mouse islets improves pancreatic islet transplant performance and reduces beta cell death. J Biol Chem 278 (2003) 343
30. Lopez-Talavera J.C., Garcia-Ocaña A., Sipula I., et al. Hepatocyte growth factor gene therapy for pancreatic islets in diabetes: reducing the minimal islet transplant mass required in a glucocorticoid-free rat model of allogeneic portal vein islet transplantation. Endocrinology 145 (2004) 467